Guest - w'd love to know what you think about the forum! Take the 2025 Survey »

DPP-IV Inhibitors Will Be the Main Class to Benefit

Thread starter Cowboyjim
Start Date Aug 1, 2011

C

Cowboyjim

Well-Known Member

Aug 1, 2011

#1

http://finance.yahoo.com/news/Type-2-Diabetes-DPPIV-bw-1155627459.html?x=0&.v=1
DPP-IV Inhibitors Will Be the Main Class to Benefit Following the Suspension of Pioglitazone Use in France and Germany

Share:

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Find support, ask questions and share your experiences - all ad free. Join the community »

This site uses cookies. By continuing to use this site, you are agreeing to our use of cookies.

Accept Learn More.…

Top